Literature DB >> 24140513

Toll-like receptor 3 plays a role in myocardial infarction and ischemia/reperfusion injury.

Chen Lu1, Danyang Ren, Xiaohui Wang, Tuanzhu Ha, Li Liu, Eric J Lee, Jing Hu, John Kalbfleisch, Xiang Gao, Race Kao, David Williams, Chuanfu Li.   

Abstract

Innate immune and inflammatory responses mediated by Toll like receptors (TLRs) have been implicated in myocardial ischemia/reperfusion (I/R) injury. This study examined the role of TLR3 in myocardial injury induced by two models, namely, myocardial infarction (MI) and I/R. First, we examined the role of TLR3 in MI. TLR3 deficient (TLR3(-/-)) and wild type (WT) mice were subjected to MI induced by permanent ligation of the left anterior descending (LAD) coronary artery for 21days. Cardiac function was measured by echocardiography. Next, we examined whether TLR3 contributes to myocardial I/R injury. TLR3(-/-) and WT mice were subjected to myocardial ischemia (45min) followed by reperfusion for up to 3days. Cardiac function and myocardial infarct size were examined. We also examined the effect of TLR3 deficiency on I/R-induced myocardial apoptosis and inflammatory cytokine production. TLR3(-/-) mice showed significant attenuation of cardiac dysfunction after MI or I/R. Myocardial infarct size and myocardial apoptosis induced by I/R injury were significantly attenuated in TLR3(-/-) mice. TLR3 deficiency increases B-cell lymphoma 2 (BCL2) levels and attenuates I/R-increased Fas, Fas ligand or CD95L (FasL), Fas-Associated protein with Death Domain (FADD), Bax and Bak levels in the myocardium. TLR3 deficiency also attenuates I/R-induced myocardial nuclear factor KappaB (NF-κB) binding activity, Tumor necrosis factor alpha (TNF-α) and Interleukin-1 beta (IL-1β) production as well as I/R-induced infiltration of neutrophils and macrophages into the myocardium. TLR3 plays an important role in myocardial injury induced by MI or I/R. The mechanisms involve activation of apoptotic signaling and NF-κB binding activity. Modulation of TLR3 may be an effective approach for ameliorating heart injury in heart attack patients.
© 2013.

Entities:  

Keywords:  Apoptosis; Inflammatory cytokine; Myocardial I/R; NF-κB; TLR

Mesh:

Substances:

Year:  2013        PMID: 24140513      PMCID: PMC3879925          DOI: 10.1016/j.bbadis.2013.10.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

1.  In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.

Authors:  R Morishita; T Sugimoto; M Aoki; I Kida; N Tomita; A Moriguchi; K Maeda; Y Sawa; Y Kaneda; J Higaki; T Ogihara
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart.

Authors:  T Kakio; A Matsumori; K Ono; H Ito; K Matsushima; S Sasayama
Journal:  Lab Invest       Date:  2000-07       Impact factor: 5.662

Review 3.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

4.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

5.  Are macrophages involved in early myocardial reperfusion injury?

Authors:  L Formigli; L I Manneschi; C Nediani; E Marcelli; G Fratini; S Z Orlandini; A M Perna
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

6.  Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.

Authors:  Jun-ichi Oyama; Charles Blais; Xiaoli Liu; Minying Pu; Lester Kobzik; Ralph A Kelly; Todd Bourcier
Journal:  Circulation       Date:  2004-02-17       Impact factor: 29.690

7.  mRNA is an endogenous ligand for Toll-like receptor 3.

Authors:  Katalin Karikó; Houping Ni; John Capodici; Marc Lamphier; Drew Weissman
Journal:  J Biol Chem       Date:  2004-01-16       Impact factor: 5.157

8.  Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart.

Authors:  Albert J Chong; Akira Shimamoto; Craig R Hampton; Hiroo Takayama; Denise J Spring; Christine L Rothnie; Masaki Yada; Timothy H Pohlman; Edward D Verrier
Journal:  J Thorac Cardiovasc Surg       Date:  2004-08       Impact factor: 5.209

9.  Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection.

Authors:  Chuanfu Li; Tuanzhu Ha; Jim Kelley; Xiang Gao; Yufeng Qiu; Race L Kao; William Browder; David L Williams
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

10.  HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.

Authors:  Jingjin Li; Yangyang Zhang; Chuanfu Li; Jian Xie; Ying Liu; Weina Zhu; Xiaojin Zhang; Surong Jiang; Li Liu; Zhengnian Ding
Journal:  Cardiovasc Res       Date:  2013-05-31       Impact factor: 10.787

View more
  28 in total

1.  Short-term pretreatment with atorvastatin attenuates left ventricular dysfunction, reduces infarct size and apoptosis in acute myocardial infarction rats.

Authors:  Tie-Long Chen; Guang-Li Zhu; Xiao-Long He; Jian-An Wang; Yu Wang; Guo-An Qi
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Innate immunity as a target for acute cardioprotection.

Authors:  Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

3.  A novel protective role for the innate immunity Toll-Like Receptor 3 (TLR3) in the retina via Stat3.

Authors:  Amit K Patel; Abigail S Hackam
Journal:  Mol Cell Neurosci       Date:  2014-09-28       Impact factor: 4.314

4.  Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Matthew D McGeough; Carla A Peña; Carlo Marchetti; Chiara Sonnino; Benjamin W Van Tassell; Fadi N Salloum; Norbert F Voelkel; Hal M Hoffman; Antonio Abbate
Journal:  Cardiovasc Res       Date:  2014-12-18       Impact factor: 10.787

5.  Adenosine 2A Receptor Activation Attenuates Ischemia Reperfusion Injury During Extracorporeal Cardiopulmonary Resuscitation.

Authors:  James H Mehaffey; Dustin Money; Eric J Charles; Sarah Schubert; Angela Fernandez Piñeros; Di Wu; Sai Vineela Bontha; Robert Hawkins; Nicholas R Teman; Victor E Laubach; Valeria R Mas; Curtis G Tribble; Daniel G Maluf; Ashish K Sharma; Zequan Yang; Irving L Kron; Mark E Roeser
Journal:  Ann Surg       Date:  2019-06       Impact factor: 12.969

Review 6.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 7.  The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine.

Authors:  Walter G Land
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

8.  Pretreatment with low-dose gadolinium chloride attenuates myocardial ischemia/reperfusion injury in rats.

Authors:  Min Chen; Yuan-yuan Zheng; Yun-tao Song; Jing-yi Xue; Zheng-yang Liang; Xin-xin Yan; Da-li Luo
Journal:  Acta Pharmacol Sin       Date:  2016-03-07       Impact factor: 6.150

9.  Human myocardium releases heat shock protein 27 (HSP27) after global ischemia: the proinflammatory effect of extracellular HSP27 through toll-like receptor (TLR)-2 and TLR4.

Authors:  Chunhua Jin; Joseph C Cleveland; Lihua Ao; Jilin Li; Qingchun Zeng; David A Fullerton; Xianzhong Meng
Journal:  Mol Med       Date:  2014-06-09       Impact factor: 6.354

10.  Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling.

Authors:  Chen Lu; Xiaohui Wang; Tuanzhu Ha; Yuanping Hu; Li Liu; Xia Zhang; Honghui Yu; Jonathan Miao; Race Kao; John Kalbfleisch; David Williams; Chuanfu Li
Journal:  J Mol Cell Cardiol       Date:  2015-10-13       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.